官方服务：
资源简介：
AR ChIP-seq(COVID19)
应用场景：
创建时间：
2020-12-22
相关数据集
Androgen receptor cistrome in breast cancer cell line MDA-MB-453 with 5a-dihydrotestosterone (DHT) stimulation. Homo sapiens
Androgen receptor (AR) is expressed in 60-70% of breast cancers independent of estrogen receptor (ER) expression, however its function in breast cancer is largely unknown. Our study identified the hig
NIAID Data Ecosystem50
ChIP-seq of the androgen receptor (AR) in MDAMB453 cells after androgen stimulation
Serum starved MDAMB453 cells were serum starved and treated for 4 hours with vehicle control (ethanol), 5a-dihydrotestosterone (DHT; 10nM) or medroxyprogesterone acetate (MPA; 10nM). AR binidng peaks
NIAID Data Ecosystem20
Genes and mechanisms regulated by androgens as possible contributors to the male excess observed in autism [LNCaP]
We optimized ChIP-sequencing protocole and anti-androgen receptor (AR) antibodies on human prostate cancer cell line (LNCaP) after either DMSO (solvent) or DHT 100nM 4 hours treatment. Overall design:
NIAID Data Ecosystem10
Androgen receptor DNA binding in response to different ligands across three prostate cancer cell lines
We performed AR ChIP-seq in LNCaP-AR, VCaP and CWR22PC cells in the presence of vehicle, androgen, or androgen plus antiandrogen. These three cell lines showed variable sensitivity to these drugs. To
NIAID Data Ecosystem30
Effect of castration, bicalutamide, and enzalutamide on androgen receptor binding in Hi-Myc mouse prostate tumors. Mus musculus
Effect of castration, bicalutamide, and enzalutamide on androgen receptor binding in Hi-Myc mouse prostate tumors Overall design: Androgen receptor ChIP-seq was performed on Hi-Myc mice tumors 3 days
NIAID Data Ecosystem20
